The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants
Open accessAbstract
BACKGROUND: Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo-oxygenase inhibitor, may be as effective as indomethacin with fewer adverse effects. OBJECTIVES: To determine the effectiveness and safety of ibuprofen compared with indomethacin, other cyclo-oxygenase inhibitor(s), placebo, or no intervention for closing a patent ductus arteriosus in preterm, low-birth-weight, or preterm and low-birth-weight infants. SEARCH METHODS: We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL 2017, Issue 10), MEDLINE via PubMed (1966 to 30 November 2017), Embase (1980 to 30 November 2017), and CINAHL (1982 to 30 November 2017). We searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles for randomised controlled trials and quasi-randomised trials. SELECTION CRITERIA: Randomised or quasi-randomised controlled trials of ibuprofen for the treatment of a PDA in preterm, low birth weight, or both preterm and low-birth-weight newborn infants. DATA COLLECTION AND ANALYSIS: Data collection and analysis conformed to the methods of the Cochrane Neonatal Review Group. We used the GRADE approach to assess the quality of evidence. MAIN RESULTS: = 4% for RR and 0% for RD); moderate-quality evidence). Early versus expectant administration of IV ibuprofen, echocardiographically-guided IV ibuprofen treatment versus standard IV ibuprofen treatment, continuous infusion of ibuprofen versus intermittent boluses of ibuprofen, and rectal ibuprofen versus oral ibuprofen were studied in too few trials to allow for precise estimates of any clinical outcomes. AUTHORS' CONCLUSIONS: Ibuprofen is as effective as indomethacin in closing a PDA. Ibuprofen reduces the risk of NEC and transient renal insufficiency. Therefore, of these two drugs, ibuprofen appears to be the drug of choice. The effectiveness of ibuprofen versus paracetamol is assessed in a separate review. Oro-gastric administration of ibuprofen appears as effective as IV administration. To make further recommendations, studies are needed to assess the effectiveness of high-dose versus standard-dose ibuprofen, early versus expectant administration of ibuprofen, echocardiographically-guided versus standard IV ibuprofen, and continuous infusion versus intermittent boluses of ibuprofen. Studies are lacking evaluating the effect of ibuprofen on longer-term outcomes in infants with PDA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
(1989) · Pediatric Research · doi:10.1203/00006450-198902000-00010 · Cited by 879
Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants
Schmidt, B., Davis, P., Moddemann, D., Ohlsson, A., Roberts, R. S., Saigal, S., Solimano, A., Vincer, M., & Wright, L. L. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442602 · Cited by 725
Self-citationVariations in Practice and Outcomes in the Canadian NICU Network: 1996–1997
Lee, S. K., McMillan, D. D., Ohlsson, A., Pendray, M., Synnes, A., Whyte, R., Chien, L.-Y., Sale, J., & the Canadian NICU Network (2000) · Pediatrics · doi:10.1542/peds.106.5.1070 · Cited by 490
Self-citationProphylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
Fowlie, P. W., Davis, P. G., & McGuire, W. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000174.pub2 · Cited by 480
WHITTLE, P. M. (1998) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.79.2.f160 · Cited by 472
A Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus
Van Overmeire, B., Smets, K., Lecoutere, D., Van de Broek, H., Weyler, J., De Groote, K., & Langhendries, J.-P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431001 · Cited by 447
Cited by
European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., et al. (2019) · Neonatology · doi:10.1159/000499361 · Cited by 1,613
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., et al. (2023) · Neonatology · doi:10.1159/000528914 · Cited by 704
Mitra, S., Florez, I. D., Tamayo, M. E., Mbuagbaw, L., Vanniyasingam, T., Veroniki, A. A., Zea, A. M., Zhang, Y., Sadeghirad, B., & Thabane, L. (2018) · JAMA · doi:10.1001/jama.2018.1896 · Cited by 324
Backer, C. L., Eltayeb, O., Mongé, M. C., Mazwi, M. L., & Costello, J. M. (2016) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000786 · Cited by 13
Metadata
- Authors
- Ohlsson, A., Walia, R., & Shah, S. S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-02-18
- Volume
- 2
- Issue
- 2
- Pages
- CD003481-CD003481
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1957857943
- Cited by
- 334
- References
- 27
- FWCI
- 21.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. https://app.cochat.ai/papers/10.1002/14651858.cd003481.pub6
- The paper
- Ohlsson, A., Walia, R., & Shah, S. S. (2015). Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd003481.pub6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.